Market Tracker

10/30 8:39am ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

Wednesday’s Trading Day
109.91 -4.16 / -3.65%
Data as of Oct 29
Day’s Change
Thursday’s Pre-Market   Switch to standard view »
108.65 -1.26 / -1.15%
 
Volume: 2.7K

Today’s Trading

Previous close114.07
Today’s open113.83
Day’s range-- - --
Volume2,449,051
Average volume (3 months)1,661,608
Market cap$26.2B
Dividend yield--
Data as of 10/29/2014

Growth & Valuation

Earnings growth (last year)-296.00%
Earnings growth (this year)-47.84%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-20.63%
P/E ratioNM
Price/Sales13.79
Price/Book18.94

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC-1.17-0.75%
MYLMylan Inc-0.86-1.66%
ZTSZoetis Inc-0.39-1.05%
ALXNAlexion Pharmaceutic...-1.71-0.89%
Data as of 10/29/2014

Financials

Next reporting dateFebruary 5, 2015
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$1.2B
Annual profit (last year)-$445.0M
Net profit margin-36.72%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeff M. Leiden
Chief Financial Officer &
Executive Vice President
Ian F. Smith
Corporate headquarters
Cambridge, Massachusetts

Forecasts